MedTrace Logo

Genetically Informed Screening for Early-Stage Type 1 Diabetes

NCT07802496 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-09-03

No results posted yet for this study

Summary

This study is a test to find out if genetic information can be used to help healthcare providers identify diseases. Specifically, the investigators want to find out how genetic information can help healthcare providers identify people who may benefit from early screening for type 1 diabetes, even before people feel sick. This study aims to guide future research to improve screening, prevent disease, slow progression, and expand treatment options for type 1 diabetes.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Aaron Leong, MD, MSc · Massachusetts General Hospital

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-10-15
Primary Completion
2029-10-01
Completion
2030-10-01

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07802496 on ClinicalTrials.gov